ClinicalTrials.Veeva

Menu

Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use (GSPE)

J

Jie Qiu

Status and phase

Completed
Phase 2

Conditions

Atherosclerosis of Arteries of the Extremities, Unspecified

Treatments

Other: lifestyle intervention
Drug: GSPE

Study type

Interventional

Funder types

Other

Identifiers

NCT01707615
2010GGC10294

Details and patient eligibility

About

The purpose of this study is to investigate the antiatherogenic effect of GSPE in clinical use

Full description

Atherosclerotic plaques indicate the occurrence of ischemia events and how to deal with it is a difficult task for clinical physicians. Grape seed proanthocyanidin extrat (GSPE) has been reported to exert an antiatherogenic effect by inducing regression of atherosclerotic plaques in animal experimental studies. In this study, the antiatherogenic effect of GSPE has been investigated in clinical use.

Enrollment

287 patients

Sex

All

Ages

43 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1) carotid ultrasound examination: presence of carotid plaque or abnormal CIMT of between 0.9 and 1.2mm; (2) lipid profile: LDL≦3.12mmol/L, TC≦5.2mmol/L; (3) no lipid-lowering treatment within the past 6 months.

Exclusion criteria

  • severe cardiomyopathy, acute coronary syndrome, hepatic dysfunction, end-stage renal failure (serum creatinine ≥117mmol/L), prior carotid endarterectomy, and/or patients who did not agree to participate in the present study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

287 participants in 2 patient groups

control group
Other group
Description:
In the control group, all patients were enrolled in a lifestyle intervention
Treatment:
Other: lifestyle intervention
GSPE group
Active Comparator group
Description:
GSPE 240 mg/day (120mg bid) in addition to the same lifestyle intervention.
Treatment:
Other: lifestyle intervention
Drug: GSPE

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems